Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits.
BACKGROUND: Vein graft stenosis is a common problem after bypass surgery. Vein grafts are ideal targets for gene therapy because transduction can be made ex vivo before grafting. Since chemokines and inflammatory factors are involved in vein graft thickening, we tested a hypothesis that the vaccini...
| Үндсэн зохиолчид: | , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Хэл сонгох: | English |
| Хэвлэсэн: |
2005
|
| _version_ | 1826268121543999488 |
|---|---|
| author | Puhakka, H Turunen, P Gruchala, M Bursill, C Heikura, T Vajanto, I Greaves, D Channons, K Ylä-Herttuala, S |
| author_facet | Puhakka, H Turunen, P Gruchala, M Bursill, C Heikura, T Vajanto, I Greaves, D Channons, K Ylä-Herttuala, S |
| author_sort | Puhakka, H |
| collection | OXFORD |
| description | BACKGROUND: Vein graft stenosis is a common problem after bypass surgery. Vein grafts are ideal targets for gene therapy because transduction can be made ex vivo before grafting. Since chemokines and inflammatory factors are involved in vein graft thickening, we tested a hypothesis that the vaccinia virus anti-inflammatory protein 35K which can sequester CC-chemokines, can reduce vein graft thickening in vivo. MATERIALS AND METHODS: We used adenovirus-mediated gene transfer (1x10(9) pfu/ml) of 35K and compared its effects on reducing stenosis in a rabbit jugular vein graft model with tissue inhibitor of metalloproteinase-1 (TIMP-1) and LacZ control gene. TIMP-1 was used in this study because it has previously been shown to inhibit vein graft stenosis in other model systems. The expression of transgenes in the transduced segments was confirmed by RT-PCR. Vein grafts were analyzed using immunohistological and morphometric methods at the three-day time-point and at two-week and four-week time-points. RESULTS: It was found that the anti-inflammatory protein 35K was an efficient factor in reducing neointima formation at the two-week time-point, indicating that inflammatory factors play an important role in vein graft stenosis. At the four-week time-point, 35K still showed a reduced accumulation of macrophages. TIMP-1 also tended to reduce neointimal thickening at the two-week time-point as compared to LacZ. CONCLUSION: It was found that 35K is an efficient factor in reducing neointima formation, macrophage accumulation and proliferation in rabbit vein grafts after adenoviral ex vivo gene transfer. |
| first_indexed | 2024-03-06T21:04:44Z |
| format | Journal article |
| id | oxford-uuid:3c0ecbdb-877c-4e44-b545-ad1fe73a8470 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:04:44Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:3c0ecbdb-877c-4e44-b545-ad1fe73a84702022-03-26T14:11:20ZEffects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3c0ecbdb-877c-4e44-b545-ad1fe73a8470EnglishSymplectic Elements at Oxford2005Puhakka, HTurunen, PGruchala, MBursill, CHeikura, TVajanto, IGreaves, DChannons, KYlä-Herttuala, S BACKGROUND: Vein graft stenosis is a common problem after bypass surgery. Vein grafts are ideal targets for gene therapy because transduction can be made ex vivo before grafting. Since chemokines and inflammatory factors are involved in vein graft thickening, we tested a hypothesis that the vaccinia virus anti-inflammatory protein 35K which can sequester CC-chemokines, can reduce vein graft thickening in vivo. MATERIALS AND METHODS: We used adenovirus-mediated gene transfer (1x10(9) pfu/ml) of 35K and compared its effects on reducing stenosis in a rabbit jugular vein graft model with tissue inhibitor of metalloproteinase-1 (TIMP-1) and LacZ control gene. TIMP-1 was used in this study because it has previously been shown to inhibit vein graft stenosis in other model systems. The expression of transgenes in the transduced segments was confirmed by RT-PCR. Vein grafts were analyzed using immunohistological and morphometric methods at the three-day time-point and at two-week and four-week time-points. RESULTS: It was found that the anti-inflammatory protein 35K was an efficient factor in reducing neointima formation at the two-week time-point, indicating that inflammatory factors play an important role in vein graft stenosis. At the four-week time-point, 35K still showed a reduced accumulation of macrophages. TIMP-1 also tended to reduce neointimal thickening at the two-week time-point as compared to LacZ. CONCLUSION: It was found that 35K is an efficient factor in reducing neointima formation, macrophage accumulation and proliferation in rabbit vein grafts after adenoviral ex vivo gene transfer. |
| spellingShingle | Puhakka, H Turunen, P Gruchala, M Bursill, C Heikura, T Vajanto, I Greaves, D Channons, K Ylä-Herttuala, S Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits. |
| title | Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits. |
| title_full | Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits. |
| title_fullStr | Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits. |
| title_full_unstemmed | Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits. |
| title_short | Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits. |
| title_sort | effects of vaccinia virus anti inflammatory protein 35k and timp 1 gene transfers on vein graft stenosis in rabbits |
| work_keys_str_mv | AT puhakkah effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT turunenp effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT gruchalam effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT bursillc effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT heikurat effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT vajantoi effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT greavesd effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT channonsk effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits AT ylaherttualas effectsofvacciniavirusantiinflammatoryprotein35kandtimp1genetransfersonveingraftstenosisinrabbits |